|

Heart Disease Clinical Trials in Sacramento, CA

31 recruiting studies within 50 miles

Phase
Trial Phase Dist.
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3<1 mi
Assessment of CCM in HF With Higher Ejection FractionN/A<1 mi
Randomized Trial of the Neochord DS1000 System Versus Open Surgical RepairN/A<1 mi
Factors Affect Outcomes in Cardiovascular Surgery<1 mi
PARTNER 3 Trial - Aortic Valve-in-ValveN/A<1 mi
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFPhase 3<1 mi
PREEMIE: Study for Treatment of PDA in Premature InfantsN/A<1 mi
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3<1 mi
Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular EventsN/A<1 mi
Cephea Early Feasibility StudyN/A<1 mi
The Fourth Left Atrial Appendage Occlusion StudyN/A<1 mi
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets<1 mi
Heart Failure Precision Medicine StudyN/A<1 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/A<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease<1 mi
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy<1 mi
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsN/A<1 mi
Pediatric Prehospital Airway Resuscitation TrialN/A<1 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3<1 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/A<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3<1 mi
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)Phase 3<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3<1 mi
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular ZincN/A14 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 316 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisPhase 2/331 mi
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationPhase 345 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 345 mi
Product Surveillance Registry47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.